• Beta-2 Glycoprotein 1 Antibody Panel (IgA, IgG, IgM)
  • ATP-binding cassette transporter A1 (ABCA1) Genotyping
  • Hepatitis B Surface Antibody, Quantitative
  • Diphenhydramine, Urine
  • Rubella Antibody, IgG
  • c-KIT Mutation Analysis, Blood, Bone Marrow
  • HLA-B*57:01 Genotype, Abacavir Sensitivity
  • Familial Dysautonomia Genetic Mutation Analysis
  • Zolpidem, Urine
  • B-Type Natriuretic Peptide (BNP) or Pro B-Type Natriuretic Peptide (Pro BNP)
  • LDS
  • Sign up
  • Log in
  • LDS
  • /Medical Tests
  • /DetermaRx for Lung Cancer Disease Management
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References

DetermaRx for Lung Cancer Disease Management
Medical Test

Overview
Access to DetermaRx for Lung Cancer Disease Management is restricted.
Loading...